Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency
- 16 July 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 106 (4) , 863-877
Abstract
This study tested the hypothesis that mucosa associated lymphoid tissue 1 (Malt1) deficiency causes osteoporosis in mice by increasing osteoclastogenesis and osteoclast activity. A patient with combined immunodeficiency (CID) caused by MALT1 deficiency had low bone mineral density resulting in multiple low impact fractures that was corrected by hematopoietic stem cell transplant (HSCT). We have reported that Malt1 deficient Mϕs, another myeloid cell type, are hyper-responsive to inflammatory stimuli. Our objectives were to determine whether Malt1 deficient mice develop an osteoporosis-like phenotype and whether it was caused by Malt1 deficiency in osteoclasts. We found that Malt1 deficient mice had low bone volume by 12 weeks of age, which was primarily associated with reduced trabecular bone. Malt1 protein is expressed and active in osteoclasts and is induced by receptor activator of NF-κB ligand (RANKL) in preosteoclasts. Malt1 deficiency did not impact osteoclast differentiation or activity in vitro. However, Malt1 deficient (Malt1−/−) mice had more osteoclasts in vivo and had lower levels of serum osteoprotegerin (OPG), an endogenous inhibitor of osteoclastogenesis. Inhibition of Malt1 activity in Mϕs induced MCSF production, required for osteoclastogenesis, and decreased OPG production in response to inflammatory stimuli. In vitro, MCSF increased and OPG inhibited osteoclastogenesis, but effects were not enhanced in Malt1 deficient osteoclasts. These data support the hypothesis that Malt1 deficient mice develop an osteoporotic phenotype with increased osteoclastogenesis in vivo, but suggest that this is caused by inflammation rather than an effect of Malt1 deficiency in osteoclasts.Keywords
This publication has 66 references indexed in Scilit:
- Paracaspase MALT1 Deficiency Protects Mice from Autoimmune-Mediated DemyelinationThe Journal of Immunology, 2013
- The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cellsJournal of Clinical Investigation, 2012
- Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell linesProceedings of the National Academy of Sciences, 2011
- Alternative activation of macrophages by IL‐4 requires SHIP degradationEuropean Journal of Immunology, 2011
- Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsetsJournal of Experimental Medicine, 2009
- SHIP prevents lipopolysaccharide from triggering an antiviral response in miceBlood, 2009
- IκB kinase β–induced phosphorylation of CARMA1 contributes to CARMA1–Bcl10–MALT1 complex formation in B cellsJournal of Experimental Medicine, 2007
- Regulation of NF-κB-Dependent Lymphocyte Activation and Development by ParacaspaseScience, 2003
- Dectin-1 Is A Major β-Glucan Receptor On MacrophagesJournal of Experimental Medicine, 2002
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999